article thumbnail

Sanofi inks 3 distribution pacts in India and Korea for CNS drugs and vaccines

Fierce Pharma

For various reasons, pharma firms often favor distribution pacts rather than relying on local subsidiaries to market their drugs. |

article thumbnail

What does the future of specialist distribution look like?

Fierce Pharma

How will specialty distribution keep up? Joining us on this episode of The Top Line is Jeff Beck, Chief Development Officer at BioCare. | The patient journey is evolving.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Novartis floats share distribution scheme as it plots Sandoz spinoff for Oct. 4

Fierce Pharma

Novartis’ Sandoz spinoff is right around the corner, and, to celebrate the occasion, the Swiss pharma is plotting a special stock distribution scheme. Novartis’ Sandoz spinoff is right around the corner, and to celebrate the occasion, the Swiss pharma is plotting a special stock distribution scheme.

article thumbnail

Orchestrating Care in the New World of Distributive Access

MedCity News

The challenge with the emerging model of “distributive access” is that there isn’t any one individual or entity coordinating everything; patients are left to navigate their own care journeys. The post Orchestrating Care in the New World of Distributive Access appeared first on MedCity News.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support studies throughout (..)

article thumbnail

Edenbridge selects PANTHERx to distribute Yargesa capsules

Pharmaceutical Technology

Edenbridge Pharmaceuticals has selected PANTHERx Rare to distribute Yargesa (miglustat) capsules for the treatment of Type 1 Gaucher disease.

article thumbnail

Pharma Distribution: Carving New Ground

Pharmaceutical Commerce

Pharmaceutical distribution today is anything but monolithic. While companies in this space are grappling with issues ranging from inflation and supply chain disruption to workforce scarcity and DSCSA implementation, there’s still plenty of room for smaller players to stake out part of the terrain to call their own.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial.

article thumbnail

Making the Case for Case Management for Cell and Gene Therapies

A dedicated Case Manager provides end-to-end supply chain management and 24/7 oversight and support to help ensure the seamless manufacturing and distribution of each therapy dose to every patient.